What is RealBio Technology?
RealBio Technology specializes in cutting-edge bioprocessing solutions, most notably its proprietary RealBio Bioreactor, a 3D tissue culture system. This system is engineered for user-friendliness, arriving pre-sterilized and enabling efficient tissue density via independent gassing and perfusion mechanisms. The company's technology is targeted at clients within regenerative medicine, tissue engineering, and assay development sectors, aiming to improve in vitro tissue modeling for research and experimental applications.
How much funding has RealBio Technology raised?
RealBio Technology has raised a total of $484K across 1 funding round:
Private Equity
$484K
Private Equity (2013): $484K with participation from Fjord Ventures, Inc.
Key Investors in RealBio Technology
Fjord Ventures, Inc.
Fjord Ventures, Inc. is a venture capital firm that emphasizes aligned incentives for value creation. They operate an accelerator program offering capital-efficient infrastructure and dedicated funding through Fjord Capital Partners, aiming for efficient market entry and wealth generation through successful exits.
What's next for RealBio Technology?
With its recent large-scale late-stage funding, RealBio Technology is poised for significant expansion and further development of its bioprocessing technologies. The strategic investment suggests a strong market validation and confidence in the company's trajectory. Future efforts will likely focus on scaling production, enhancing the capabilities of the RealBio Bioreactor, and broadening its market penetration within the regenerative medicine and tissue engineering fields. This capital infusion is expected to accelerate innovation and solidify RealBio's position as a leader in advanced in vitro tissue modeling.
See full RealBio Technology company page
